Two studies published in JAMA Neurology look at diabetes drugs and the risk of dementia and Alzheimer’s. Comments on both studies: … read more
A platform trial published in The Lancet Neurology looks at the efficacy of anti-amyloid drugs that could delay the onset of Alzheimer’s … read more
An observational study published in Nature Medicine looks at a link between abnormal brain proteins and COVID-19 infection. Prof Tara … read more
A systematic review published in Alzheimer’s and Dementia: Translational Research & Clinical Interventions looks at the association between prescribed drugs and … read more
A study published in Science Signalling looks at brain tissue injury in a dish, and the reactivation of latent HSV-1 virus that … read more
A study published in The BMJ looks at Alzheimer’s disease mortality among taxi and ambulance drivers. Dr Richard Oakley, Associate Director … read more
A study published in PNAS looks at a nasal treatment for Alzheimer’s disease in mice. Dr Richard Oakley, Associate Director of … read more
Scientists comment on MHRA saying ‘Donanemab licensed for treatment of Alzheimer’s disease in some adults’, and NICE draft guidance saying … read more
Scientists comment on both MHRA and NICE news on lecanemab for Alzheimer’s disease. Fiona Carragher, Chief Policy and Research … read more
With the announcement on 22nd August 2024 from the MHRA and NICE on lecanemab for Alzheimer’s Disease, journalists heard from … read more
A perspective article published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association looks at challenges for new Alzheimer’s drugs. … read more
A conference abstract presented at the Alzheimer’s Association International Conference looks at red meat intake and dementia risk. Dr Richard … read more
Scientists react to findings presented at the Alzheimer’s Association International Conference (AAIC) 2024 about continuous treatment with lecanemab. Prof … read more
A conference abstract at the Alzheimer’s Association International Conference looks at weight loss drug liraglutide and Alzheimer’s disease. Dr … read more
Scientist comment on the EMA decision on the use of lecanemab for Alzheimer’s disease. Prof Robert Howard, Professor of … read more
A study published in Nature Medicine looks at the genetic variants and Alzheimer’s disease. Prof Jonathan Schott, Chief Medical Officer at … read more
A study published in The BMJ looks at antipsychotic use in people with dementia. Dr Richard Oakley, Associate Director of … read more
A study published in Stem Cell Reports looks at a stem cell transplant in mice and transmission of a familial form of … read more
Scientists react to news that the FDA are delaying a decision on the Alzheimer’s drug Donanemab. Prof Robert Howard, … read more
A study published in Nature Aging looks at possible plasma protein biomarkers for dementia risk. Dr Sheona Scales, Director of Research … read more
